Items where authors include "Sivaprasad, S."

Article

Short, E. orcid.org/0000-0001-5050-589X, Adcock, I.M., Al-Sarireh, B. et al. (224 more authors) (2024) Defining an ageing-related pathology, disease or syndrome: international consensus statement. GeroScience. ISSN 2509-2715

Pennington, R., Alshreef, A., Flight, L. orcid.org/0000-0002-9569-8290 et al. (12 more authors) (2021) Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study. PharmacoEconomics, 39 (8). pp. 913-927. ISSN 1170-7690

Hykin, P., Prevost, A.T., Sivaprasad, S. et al. (16 more authors) (2021) Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment, 25 (38). ISSN 1366-5278

Pennington, B.M., Hernández-Alava, M., Hykin, P. et al. (4 more authors) (2020) Mapping from visual acuity to EQ-5D, EQ-5D with vision bolt-on, and VFQ-UI in patients with macular edema in the LEAVO trial. Value in Health, 23 (7). pp. 928-935. ISSN 1098-3015

Proceedings Paper

Flight, L. orcid.org/0000-0002-9569-8290, Alshreef, A. orcid.org/0000-0003-2737-1365, Hykin, P.G. et al. (5 more authors) (2019) Intravitreal therapy with ranibizumab vs aflibercept vs bevacizumab for macular oedema due to central retinal vein occlusion : a within trial cost-utility analysis. In: Value in Health. ISPOR Europe 2019, 02-06 Nov 2019, Copenhagen, Denmark. Elsevier , S664-S664.

Pennington, B., Alshreef, A. orcid.org/0000-0003-2737-1365, Flight, L. orcid.org/0000-0002-9569-8290 et al. (4 more authors) (2019) PSS25 Mapping from visual acuity to utility in patients with macular oedema due to central retinal vein occlusion using data from the LEAVO trial. In: Value in Health. ISPOR Europe 2019, 02-06 Nov 2019, Copenhagen, Denmark. Elsevier , S891-S891.